Vcanbio Cell&Gene Engineering Corp.,Ltd’s Net Profit Rose 27.8% in First Half of 2023

Vcanbio Cell&Gene Engineering Corp.,Ltd (中源协和细胞基因工程股份有限公司) (600645.SH) reported a net profit of 81.6 million yuan in the first half of 2023, up 27.8% year-on-year.

Meanwhile, the company posted 798.1 million yuan in revenue, up 3.8% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 29.9%.